Search

Search module

Refined by:
Results 31 to 40 of 598 for 'chi2 news'. 51 results match all words and 547 results match some words.
Clear all filters
Limit the number of results to display
Sort results by
Card view List view

Fully-matching results

Dissecting Time-Varying Risk Exposures in Cryptocurrency…

https://www.bath.ac.uk/events/dissecting-time-varying-risk-exposures-i…

hype surrounding the surge of Bitcoin valuations) that cryptocurrencies represent a new asset class, spanning risks and payoffs sufficiently different from the traditional ones.

Business and human rights for Global Supply Chains - what …

https://www.bath.ac.uk/events/business-and-human-rights-for-global-sup…

According to new estimates from the International Labor Organization, 27.6 million people are in a situation of forced labor. ... The expert speakers will consider the role of legislation, supply chain management practices, and new business models.

The challenge of climate-related stress testing

https://www.bath.ac.uk/events/the-challenge-of-climate-related-stress-…

The design of the stress tests themselves can have economic consequences as it influences the flow of funds to new and old technologies and industries.

Property rights, owner-management and economic value…

https://www.bath.ac.uk/events/property-rights-owner-management-and-eco…

Our theory sheds new light on the governance of owner-managed firms and explains variance in their ability to create value. ... His research also received several international awards and has been discussed in the international media such as in The

The attractiveness of university and corporate anchor…

https://www.bath.ac.uk/events/the-attractiveness-of-university-and-cor…

The attractiveness of university and corporate anchor tenants in the conception of a new cluster. ... This talk focuses on a proposal to develop a new tech-based cluster in the UK.

Market Size and Innovation: the Case of Covid-19 and…

https://www.bath.ac.uk/events/market-size-and-innovation-the-case-of-c…

We find: (1) a highly elastic directed R&D response to fight COVID-19 with 40% of all new clinical trials directed towards COVID-19 by May 2020 ; (2) while other